Bpth stock price today
View recent trades and share price information for Bio-Path Holdings Inc USD0. 001. Bio-Path Holdings Inc (BPTH) USD0.001. Sell:$4.76 Buy:$5.10 To buy US shares you must first complete and return a US government 'W-8BEN' form. BPTH Stock Price | Bio-Path Holdings Inc. Stock Quote (U.S ... BPTH | Complete Bio-Path Holdings Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. BPTH Stock Quote - Bio-Path Holdings, Inc. Stock Price Today
BPTH | Complete Bio-Path Holdings Inc. stock news by MarketWatch. View real- time stock prices and stock quotes for a full financial overview.
BPTH | Complete Bio-Path Holdings Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. BPTH Stock Quote - Bio-Path Holdings, Inc. Stock Price Today BPTH stock quote, chart and news. Get Bio-Path Holdings, Inc.'s stock price today. Bio-path Holdings, Inc. - BPTH - Stock Price Today - Zacks View Bio-Path Holdings, Inc. BPTH investment & stock information. Get the latest Bio-Path Holdings, Inc. BPTH detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Bio-Path Holdings, Inc. (BPTH) Latest Stock News ...
Bio-Path Holdings, Inc. Common Stock (BPTH) Real-Time ...
Oct 25, 2019 · 1 Wall Street analysts have issued ratings and price targets for Bio-Path in the last 12 months. Their average twelve-month price target is $25.00, suggesting that the stock has a possible upside of 441.13%. The high price target for BPTH is $25.00 and the low price target for BPTH is $25.00. Bio-Path Holdings Inc. (BPTH) Stock Quote | Price Chart ... View a financial market summary for BPTH including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to BPTH (Bio-Path Holdings Inc.) stock. Earnings Whisper Number for BPTH: Bio-Path Aug 15, 2019 · Bio-Path (BPTH) reports earnings on 6/5/2020. Shares are down 5.9% since reporting last quarter. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings.
BPTH stock rating and analysis - Bio-Path Holdings : a summary of key financial strength and profitability metrics. Price-to-Tangible-Book, 0.69. Earnings Yield
Bio-Path Holdings, Inc., (BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced its financial results for the full year ended December 31, 2019 and provided an update on recent corporate developments.
bio-path holdings announces successful completion of safety testing in stage 2 of phase 2 clinical trial in acute myeloid leukemianov 26 2019. bio-path holdings announces clearance of investigational new drug application for bp1002nov 21 2019. bio-path holdings reports third quarter 2019 financial resultsnov 15 …
BPTH | Bio-Path Holdings Inc. Stock Price & News - WSJ View the latest Bio-Path Holdings Inc. (BPTH) stock price, news, historical charts, analyst ratings and financial information from WSJ. BPTH | Bio-Path Holdings Inc. Advanced Charts | MarketWatch
Mar 01, 2019 · Bio-Path Holdings Inc (NASDAQ: BPTH) is rocketing in the market this morning, more than doubling in value. The gains come on the heals of a press release, announcing that the company will be … BPTH Historical Stock Prices Bio-Path Holdings (BPTH) has the following price history information. Looking back at BPTH historical stock prices for the last five trading days, on February 03, 2020, BPTH opened at $6.32, traded as high as $6.75 and as low as $6.20, and closed at $6.57. Trading volume was a total of 68.40K shares. Bio-Path Holdings, Inc. (BPTH) Stock Price, Quote, History ... Bio-Path Holdings, Inc., (BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced its financial results for the full year ended December 31, 2019 and provided an update on recent corporate developments. Bio-Path Holdings (BPTH) Stock: Continuing Skyward On ...